Anixa Begin Period Cash Flow from 2010 to 2024
| ANIX Stock | USD 3.30 0.01 0.30% |
Begin Period Cash Flow | First Reported 1990-01-31 | Previous Quarter 998 K | Current Value 995 K | Quarterly Volatility 6.2 M |
Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.
Anixa | Begin Period Cash Flow |
Latest Anixa Biosciences' Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Anixa Biosciences over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Anixa Biosciences' Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Anixa Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 6,724,090 | |
| Geometric Mean | 3,635,570 | |
| Coefficient Of Variation | 116.74 | |
| Mean Deviation | 5,830,712 | |
| Median | 3,361,246 | |
| Standard Deviation | 7,849,681 | |
| Sample Variance | 61.6T | |
| Range | 28.8M | |
| R-Value | 0.72 | |
| Mean Square Error | 31.9T | |
| R-Squared | 0.52 | |
| Significance | 0 | |
| Slope | 1,265,048 | |
| Total Sum of Squares | 862.6T |
Anixa Begin Period Cash Flow History
About Anixa Biosciences Financial Statements
Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 14.2 M | 14.9 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Anixa Stock Analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.